Approval · Notice of Compliance 9041 · 2007
CUBICIN: Notice of Compliance 9041
Issued September 24, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9041
- Date
- September 24, 2007
- Company
- Cubist Pharmaceuticals Llc6005 Luzern, Luzern, Switzerland
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Antibacterial agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CUBICIN | 02299909 | Cancelled Post Market |
Medicinal ingredients
- DAPTOMYCIN 500 MG per VIAL